Kristin Wold
@kristinwold.bsky.social
Clinical Psychologist
Candidate in Psychoanalytic training
Researcher with interest in course and outcome of first-episode psychosis
@NORMENT @UniOslo @OsloUnviversityHospital
Candidate in Psychoanalytic training
Researcher with interest in course and outcome of first-episode psychosis
@NORMENT @UniOslo @OsloUnviversityHospital
Reposted by Kristin Wold
👉New Article Collection!
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
The discovery of antipsychotic drugs for the treatment of schizophrenia has reshaped the landscape for the ability to treat this devastating disorder. ...
go.nature.com
November 9, 2025 at 3:38 PM
👉New Article Collection!
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
Reposted by Kristin Wold
New investigation of what lies behind the 17-year reduction in life expectancy gap between #schizophrenia patients and the general population. 2nd-gen antipsychotics and low frequency hospitalization were associated with reduced mortality @sirsofficial.bsky.social bit.ly/4gdulqF
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population? - Schizophrenia
Schizophrenia - What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?
bit.ly
September 8, 2025 at 7:14 AM
New investigation of what lies behind the 17-year reduction in life expectancy gap between #schizophrenia patients and the general population. 2nd-gen antipsychotics and low frequency hospitalization were associated with reduced mortality @sirsofficial.bsky.social bit.ly/4gdulqF
New paper from our research group presenting important insights from participants about their recovery processes @ginaaas.bsky.social
“Why shouldn’t I expect a lot from life?” Our qual paper on recovery in psychosis is out! Participants reported on their own role in their recovery and the importance of taking positive risks. SFFNORMENT @unioslo-svfak.bsky.social @kristinwold.bsky.social
doi.org/10.1186/s128...
doi.org/10.1186/s128...
“Why shouldn’t I expect a lot from life?” – a qualitative study of what facilitates long-term recovery in first-episode psychosis - BMC Psychiatry
Background Qualitative research frequently characterises recovery, but more knowledge on subjective experiences of facilitators of long-term recovery in psychosis is needed. This interview study aimed...
doi.org
April 28, 2025 at 7:44 PM
New paper from our research group presenting important insights from participants about their recovery processes @ginaaas.bsky.social
Reposted by Kristin Wold
“Why shouldn’t I expect a lot from life?” Our qual paper on recovery in psychosis is out! Participants reported on their own role in their recovery and the importance of taking positive risks. SFFNORMENT @unioslo-svfak.bsky.social @kristinwold.bsky.social
doi.org/10.1186/s128...
doi.org/10.1186/s128...
“Why shouldn’t I expect a lot from life?” – a qualitative study of what facilitates long-term recovery in first-episode psychosis - BMC Psychiatry
Background Qualitative research frequently characterises recovery, but more knowledge on subjective experiences of facilitators of long-term recovery in psychosis is needed. This interview study aimed...
doi.org
April 28, 2025 at 7:27 PM
“Why shouldn’t I expect a lot from life?” Our qual paper on recovery in psychosis is out! Participants reported on their own role in their recovery and the importance of taking positive risks. SFFNORMENT @unioslo-svfak.bsky.social @kristinwold.bsky.social
doi.org/10.1186/s128...
doi.org/10.1186/s128...
Reposted by Kristin Wold
New pathways for preventing schizophrenia: public and private partners collaborate in the international Accelerating Medicines Partnership® Schizophrenia consortium @sirsofficial.bsky.social go.nature.com/3Y89zks
Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program - Schizophrenia
Schizophrenia - Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program
go.nature.com
April 20, 2025 at 12:03 PM
New pathways for preventing schizophrenia: public and private partners collaborate in the international Accelerating Medicines Partnership® Schizophrenia consortium @sirsofficial.bsky.social go.nature.com/3Y89zks
It was great to have the possibility to present results from our long-term follow-up study of First Episode Psychosis patients at #SIRS2025 with such great colleagues ♥️ @sirsofficial.bsky.social
Thought-provoking symposium on treatment resistance, short-comings of its definitions & of treatment practice @ #SIRS2025 @sirsofficial.bsky.social w/Ingrid Melle & @kgjonas.bsky.social (chairs), Sherry KW Chan, Jose Rubio, Oliver Howes - and my wonderful colleague @kristinwold.bsky.social (here👇)
April 10, 2025 at 8:00 PM
It was great to have the possibility to present results from our long-term follow-up study of First Episode Psychosis patients at #SIRS2025 with such great colleagues ♥️ @sirsofficial.bsky.social
Reposted by Kristin Wold
Keynote on digital interventions for psychosis: Mario Alvarez-Jimenez kicking off day 3 @ #SIRS2025 @sirsofficial.bsky.social with powerful images on the omnipresence of technology in our daily lives - before elegantly demonstrating how this could be exploited to address current treatment challenges
March 31, 2025 at 2:32 PM
Keynote on digital interventions for psychosis: Mario Alvarez-Jimenez kicking off day 3 @ #SIRS2025 @sirsofficial.bsky.social with powerful images on the omnipresence of technology in our daily lives - before elegantly demonstrating how this could be exploited to address current treatment challenges
Reposted by Kristin Wold
Great symposium on self-disorders in schizophrenia at #SIRS2025 (@sirsofficial.bsky.social), spearheaded by @jfeyaerts.bsky.social, with exciting empirical findings presented by @ccrosenphd.bsky.social (20-year follow-up!) and Julia Lebovitz, and a stimulating discussion by Louis Sass.
March 30, 2025 at 5:13 PM
Great symposium on self-disorders in schizophrenia at #SIRS2025 (@sirsofficial.bsky.social), spearheaded by @jfeyaerts.bsky.social, with exciting empirical findings presented by @ccrosenphd.bsky.social (20-year follow-up!) and Julia Lebovitz, and a stimulating discussion by Louis Sass.
Looking forward to participate at the #SIRS2025 conference!
Welcome to Chicago, SIRS 2025 attendees! Let's make this conference an experience to remember. We hope you enjoy our lineup of speakers and the chance to connect with colleagues in the field.
#SIRS2025
#SIRS2025
March 29, 2025 at 1:47 PM
Looking forward to participate at the #SIRS2025 conference!
Reposted by Kristin Wold
Cognition is a core biomarker for schizophrenia & key focus in the Accelerating Medicines Partnership® (AMP SCZ) initiative. Here the authors outline the rationale and harmonization of the cognitive battery @kelly_allott @Wal_yas @ @scottwoods01.bsky.social @patmcgorry.bsky.social bit.ly/4iWAFmA
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample - Schizophrenia
Schizophrenia - Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
bit.ly
March 24, 2025 at 12:59 PM
Cognition is a core biomarker for schizophrenia & key focus in the Accelerating Medicines Partnership® (AMP SCZ) initiative. Here the authors outline the rationale and harmonization of the cognitive battery @kelly_allott @Wal_yas @ @scottwoods01.bsky.social @patmcgorry.bsky.social bit.ly/4iWAFmA
Proud to be part of my wonderful colleague @ginaaas important contribution on what patients describe as important in their recoveryprocess from First-Episode Psychosis ♥️ @SFFNORMENT @UniOslo_MED @Oslounivsykehus @i_s_melle
In an effort to not only post nonsense here:
Sharing our qual paper on service user experiences with mental health and welfare services in FEP recovery. Shared decision-making, family and peer involvement, social safety net and employment support most important link.springer.com/article/10.1...
Sharing our qual paper on service user experiences with mental health and welfare services in FEP recovery. Shared decision-making, family and peer involvement, social safety net and employment support most important link.springer.com/article/10.1...
Taking what you get or Getting what you Need: A Qualitative Study on Experiences with Mental Health and Welfare Services in Long-Term Recovery in First-Episode Psychosis - Community Mental Health Jour...
How people in long-term recovery (clinical and personal) in first-episode psychosis (schizophrenia and bipolar spectrum disorders) experience the mental health and welfare services they interact with ...
link.springer.com
November 29, 2024 at 1:16 PM
Proud to be part of my wonderful colleague @ginaaas important contribution on what patients describe as important in their recoveryprocess from First-Episode Psychosis ♥️ @SFFNORMENT @UniOslo_MED @Oslounivsykehus @i_s_melle